Esocare Capsule

About Esocare 20 mg Capsule

Esocare 20 mg Capsule is a proton pump inhibitor that reduces stomach acid. It is used for heartburn, erosive esophagitis, and H. pylori infection. The doctor decides the dose and course.

There are 161 brands of Esomeprazole listed in Bangladesh. 10 of them have a lower unit price than Esocare. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.

What is Esocare 20 mg Capsule?

Esocare 20 mg Capsule contains esomeprazole, a proton pump inhibitor that reduces stomach acid. It is used to relieve chronic heartburn and other symptoms of GERD, to heal erosive esophagitis and maintain healing, and, with other medicines, to treat H. pylori infection in duodenal ulcer disease. The capsule is taken by mouth. The doctor decides the dose and how long to take it. Do not adjust the dose without medical advice.

Uses of Esocare

Esocare 20 mg Capsule is used to relieve chronic heartburn and other symptoms of GERD. It helps heal erosive esophagitis and maintain healing. It is also used with other medicines to treat H. pylori infection in people with duodenal ulcer disease. Only a doctor can decide if it is right for you.

How to use Esocare

Take Esocare 20 mg Capsule by mouth as directed by your doctor. Swallow the capsule whole with water. If you have trouble swallowing, open the capsule and mix the pellets with a spoonful of soft applesauce (not hot), then swallow right away without chewing. Take it at least one hour before meals. The doctor decides the dose and course.

Side effects of Esocare

Common side effects of Esocare 20 mg Capsule include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation, and dry mouth. These are usually mild. Tell your doctor if side effects bother you or do not go away. Serious side effects are rare, but seek medical help if you have severe symptoms. The doctor can advise on management.

Safety and precautions

Do not take Esocare 20 mg Capsule if you are allergic to esomeprazole or any ingredient. Before starting, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding; the medicine may not be recommended. Also tell your doctor about all medicines you take, as interactions can occur. A response to treatment does not rule out stomach cancer, so your doctor may check further. Ask your doctor first if you have any concerns.

Frequently asked questions

What is Esocare 20 mg Capsule used for and what kind of medicine is it?

Esocare 20 mg Capsule is a proton pump inhibitor. It reduces stomach acid and is used for chronic heartburn and other GERD symptoms, to heal and maintain healing of erosive esophagitis, and with other medicines for H. pylori infection in duodenal ulcer disease.

How should I store Esocare 20 mg Capsule?

Store Esocare 20 mg Capsule at a temperature not exceeding 30°C in a dry place. Protect it from light and moisture. Keep it out of reach of children. Do not use after the expiry date. Ask your pharmacist if you are unsure.

Who should avoid Esocare 20 mg Capsule or ask the doctor first?

Do not take Esocare 20 mg Capsule if you are allergic to esomeprazole. Ask your doctor first if you are pregnant, planning pregnancy, or breastfeeding. Also tell your doctor about all other medicines you take, as interactions may occur. Your doctor will decide if it is safe for you.

What is the price of Esocare 20 mg Capsule?

The listed price is ৳ 6.00.

Indications

Esomeprazole is indicated:
  • To relieve from chronic heartburn symptoms and other symptoms associated with GERD
  • For the healing of erosive esophagitis
  • For maintenance of healing of erosive esophagitis
  • In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
  • ... Read more
Esomeprazole is indicated:
  • To relieve from chronic heartburn symptoms and other symptoms associated with GERD
  • For the healing of erosive esophagitis
  • For maintenance of healing of erosive esophagitis
  • In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
  • Zollinger-Ellison Syndrome
  • Acid related Dyspepsia
  • Duodenal & Gastric ulcer

Pharmacology

Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.

Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.

Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.

Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.

Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.

Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.

Dosage & Administration

Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive

Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).

Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.

Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.

Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.

Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.

Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.

Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.

Interaction

Esomeprazole is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin.

Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).

Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.

Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.

Contraindications

Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.

Side Effects

The most frequently occurring adverse events reported with Esomeprazole include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.

Pregnancy & Lactation

There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.

Precautions & Warnings

General: Symptomatic response to therapy with esomeprazole does not preclude the presence of gastric malignancy.

Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.

Overdose Effects

A single oral dose of Esomeprazole at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Esomeprazole. No specific antidote for Esomeprazole is known. Since Esomeprazole is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.

Storage Conditions

Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.

Alternative brands of Esomeprazole

Other brands with the same generic name, cheapest first.

Emo Tablet

20 mg

Esomeprazole

Pharmadesh Laboratories Ltd.

৳ 0.98 ৳ 1 2% off per unit

Epa Tablet

20 mg

Esomeprazole

Zenith Pharmaceuticals Ltd.

৳ 0.98 ৳ 1 2% off per unit

Esru Tablet

20 mg

Esomeprazole

Doctor's Chemicals Works Ltd.

৳ 3.92 ৳ 4.00 2% off per unit

Esopin Tablet

20 mg

Esomeprazole

Hallmark Pharmaceuticals Ltd.

৳ 3.94 ৳ 4.02 2% off per unit

Esofast Tablet

20 mg

Esomeprazole

S. N. Pharmaceuticals Ltd.

৳ 4.41 ৳ 4.5 2% off per unit

Eso Tablet

20 mg

Esomeprazole

Asiatic Laboratories Ltd.

৳ 4.9 ৳ 5.00 2% off per unit

Esomep Tablet

20 mg

Esomeprazole

Advanced Chemical Industries PLC

৳ 4.9 ৳ 5 2% off per unit

Exmart Tablet

20 mg

Esomeprazole

MST Pharma and Healthcare Ltd.

৳ 4.9 ৳ 5.00 2% off per unit

Ema Tablet

20 mg

Esomeprazole

Globe Pharmaceuticals Ltd.

৳ 5.88 ৳ 6 2% off per unit

Esocare Tablet

20 mg

Esomeprazole

Novelta Bestway Pharmaceuticals Ltd.

৳ 5.88 ৳ 6.00 2% off per unit

See all 161 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.